Investor Update, page-247

Yes brick

Here is a brief overview of the company anteo are dealing with...

Sinopharm Group Shanghai Jienuo Biotechnology Co., Ltd. (hereinafter referred to as “Shanghai Jienuo” is affiliated to China National Pharmaceutical Group Corporation (hereinafter referred to as “Sinopharm Group” China Biotechnology Co., Ltd. (hereinafter referred to as “China Bio”, which is China. Biotechnology's diagnostic reagents business, specializing in the sale of domestic and foreign medical devices and in vitro diagnostic reagents.

The company's products cover molecular diagnostics, microbiology, immunology, etc. The partners include multinational companies from North America, Europe, Japan and other countries and domestically renowned manufacturers in the professional field.
China Biotechnology The 13th Five-Year Strategic Plan will vigorously develop six core segments of vaccines, blood products, animal vaccines, diagnostic reagents, medical beauty and antibodies. Shanghai Jienuo's in vitro diagnostic reagents are one of the key developments in the “13th Five-Year Plan” and the first to lead the reform of China's biological hybrid ownership system. It aims to promote the rapid development of diagnostic services through institutional innovation.

As a unified operation platform for medical diagnostics in the bio-medical and bio-health industry in China, Shanghai Jienuo integrates trade, industry and science, and focuses on building sales networks and channels to promote industrial development through technology introduction and investment mergers and acquisitions.

Create a large industrial chain for building China's bio-diagnostic sector. In 2017, Shanghai Jienuo successfully won the German Oncgnostics company cervical cancer risk assessment methylation test kit and the Dutch PathoFinder 2SMART single-tube multiplex nucleic acid detection kit technology transfer authorization cooperation project. At the same time as the agent import kit, it is also preparing for the self-built production plant, transforming its testing technology, and producing high-quality domestic products to better serve the people's health.

Shanghai Jienuo's main agent products are Gyntect, Cervical cancer risk assessment methylation test kit, PathoFinder 2SMART single-tube multiplex nucleic acid detection kit, VerePLEX Biosysytem multi-microbial pathogen nucleic acid detection system, MBL autoimmune diagnostic products, etc., focusing on multiple detection and tumors of infectious disease pathogens The molecular diagnosis serves the government laboratories such as major clinical hospitals, disease prevention and control centers, inspection and quarantine bureaus, and food and drug administrations. Shanghai Jienuo takes "care for life and care for health" as its corporate philosophy. Its products are positioned in precision medicine, personalized medicine, fast and accurate detection, and play an active role in promoting people's health and industry development.